Clinical Guidelines

MENU

Supplement. Colposcopy information for discussion with patient

Supplement. Colposcopy information for discussion with patient

GUIDELINE UPDATES - This guideline was last updated 7/1/2022

Patient information

Most women attending for a colposcopy consultation have significant anxiety in advance of the appointment (see Chapter 19. Psychosocial care).[1][2][3] This is often related to uncertainty about the diagnosis and possible treatment, but may reflect concern regarding the approaching gynaecological (colposcopic) examination. Colposcopists should take measures to alleviate these anxieties while protecting each woman’s dignity and privacy. A Cochrane review of interventions to reduce anxiety in women undergoing colposcopy, which included six randomised controlled trials, found that music during colposcopy significantly reduced anxiety levels and pain during the procedure.[4] 

Effective information and communication is essential for all women. There is good evidence that accurate and well-presented information improves women’s experience of colposcopy and reduces anxiety.[5][6] Women may not remember all of the verbal information given at the time of consultation or treatment and, ideally, written information should be available where appropriate. 

Ideally, women should be given relevant information at the time of cervical screening and before colposcopy. Most hospital colposcopy clinics and many colposcopists will have their own information pamphlets or leaflets. Information is also available from proprietary sources (usually free of charge) or from the Commonwealth and state- and territory-based programs of the National Cervical Screening Program (NCSP).[7][8] 

It is essential that women be given the opportunity to discuss their management and any concerns they may have time at the time of consultation or treatment. 

Questions that women may ask include the following:

  • What do my test results mean?
  • Do I need more tests and if so, why?
  • What treatment do you advise and why?
  • Are there any other options?
  • Will I need time off work?
  • Will I be able to drive myself home after my treatment?
  • Will there be bleeding or vaginal discharge after treatment?
  • How often will I need to come back to see you?
  • When is my next check-up due?
  • Is there anything I can do to help myself in the future?
  • Can you give me some information about HPV?

Prior to the first visit for colposcopy

Written information sent to the woman should include:

  • a basic description of the causes of cervical pre-cancer and cancer and the relationship to HPV infection.
  • a list of the grades of abnormality that are reported in the screening test results with a brief explanation of what they mean.
  • a description of the colposcopic examination and possible biopsy
  • the potential outcomes of the colposcopic assessment, including commonly used treatment modalities.
  • a recommendation for post-menopausal women, people experiencing vaginal dryness, or trans men to speak to their provider about a short course of topical oestrogen therapy before the colposcopic examination to reduce discomfort from the speculum and to improve the diagnostic accuracy of colposcopy and any associated LBC and/or biopsy.

At the time of the colposcopy consultation

Colposcopists should be sensitive to the psychophysiological needs of individual women undergoing colposcopy:

  • Matching intra-procedural information with different coping styles reduces psychophysiological disturbance in women undergoing colposcopy.[9]
  • Check that the woman did receive the pre-visit information. If not she can read it while waiting for her consultation.
  • Remind the woman about the technique of colposcopy and the possible need for a cervical biopsy.
  • During the examination keep her informed as to what can be seen and what is happening and especially if and when a biopsy is taken.
  • If a video-colposcopy is available and the woman wishes to watch the colposcopic image, this should be encouraged but be aware that in some women this can cause anxiety.
  • Following the examination and if a biopsy has been performed, the woman should be given clear advice regarding the transient occurrence of mild pelvic discomfort and vaginal ‘spotting’ and should be advised to avoid sexual intercourse for a few days.
  • If a biopsy has been taken she should be given clear instructions, preferably in writing, as to how she will obtain the results of the biopsy.
  • Prior to leaving the consultation visit, particularly if it appears likely that she will require treatment, the woman should be given verbal and written information about any potential treatment procedures and their complications that may affect her consent to be treated.
  • If treatment is not likely but she needs a follow up visit or needs to see her GP, this information should be clearly articulated and should be confirmed in writing.

At the time of a treatment visit

The colposcopist should:

  • confirm that the woman understands and consents to treatment
  • if colposcopy is done under local anaesthesia, keep the woman informed about the procedure in real time
  • after the procedure, ensure that the woman is given verbal and written information about potential common complications, especially bleeding and infection and what she should do if they occur. This should be reinforced by written information, including advice as to how the pathology results of any treatment will be obtained.
  • provide information about necessary follow-up after treatment.

Post treatment

Information should include the following advice:

  • Some women experience abdominal cramps after treatment. This can feel like a painful period. It is also normal to have a dark or watery vaginal discharge for up to 4 weeks. This may include the passing of small clots while the cervix heals.
  • Avoid using tampons for 4 weeks after treatment.
  • Abstain from sexual intercourse for 4 weeks after treatment.
  • Avoid strenuous exercise or swimming for 10–14 days after treatment.
  • Some women may have temporary alteration in menstrual pattern after an excisional treatment, including heavier and more painful flow in the subsequent period.

Note: Culturally and linguistically appropriate information should be available for Aboriginal and Torres Strait Islander women and women who speak a language other than English, preferably in their first language.[10] However, it is often not possible for written information to be available in all languages. Women should be offered access to interpreter services when required (information on interpreter services can be accessed from Translating and Interpreting Services. Appropriately tailored information should also be available for anyone with a cervix, across the spectra of gender-diversity and sexual orientation including women who identify as lesbian or bisexual, and trans and gender diverse people with a cervix. 

Author(s):

References

  1. Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormal result of cervical smear test: a controlled trial. BMJ 1990 Feb 17;300(6722):440 Available from: http://www.ncbi.nlm.nih.gov/pubmed/2107898.
  2. Marteau TM, Walker P, Giles J, Smail M. Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol 1990 Sep;97(9):859-61 Available from: http://www.ncbi.nlm.nih.gov/pubmed/2242376.
  3. Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991 Sep;165(3):658-62 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1892194.
  4. Galaal K, Bryant A, Deane KH, Al-Khaduri M, Lopes AD. Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev 2011 Dec 7;(12):CD006013 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22161395.
  5. Marteau TM. Reducing anxiety in women referred for colposcopy using an information booklet. Br J Health Psych 1996;1: 181–189.
  6. Freeman-Wang T, Walker P, Linehan J, Coffey C, Glasser B, Sherr L. Anxiety levels in women attending colposcopy clinics for treatment for cervical intraepithelial neoplasia: a randomised trial of written and video information. BJOG 2001 May;108(5):482-4 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11368133.
  7. PapScreen Victoria. For women. [homepage on the internet] Victoria: Cancer Council; Available from: http://www.papscreen.org.au/forwomen.
  8. Australian Government Department of Health. National Cervical Screening Program:Cervical Screening. [homepage on the internet] Commonwealth of Australia; [cited 2016; updated 2016 Feb 9]. Available from: http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/cervical-screening-2.
  9. Kola S, Walsh JC, Hughes BM, Howard S. Matching intra-procedural information with coping style reduces psychophysiological arousal in women undergoing colposcopy. J Behav Med 2013 Aug;36(4):401-12 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22729966.
  10. Australian Commission on Safety and Quality in Health Care. Health Literacy:Taking action to improve safety and quality. Sydney: ACSQHC; 2014 [cited 2016] Available from: http://www.safetyandquality.gov.au/wp-content/uploads/2014/08/Health-Literacy-Taking-action-to-improve-safety-and-quality.pdf.

WEBSITE UPDATES - This website was last updated 7/1/2022